ArticleInflammation2026
Comprehensive Immune-Phenotyping of Peripheral Lymphocytes in Coronary Artery Disease Reveals Potential Roles of Effector Memory and PD-1⁺ CD4⁺ T Cells.
Article in Inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Immuno-inflammatory-metabolic interactions in cardiovascular diseases: a review from basic mechanisms to clinical translation.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Chronic inflammation plays a key role in the pathogenesis of coronary artery disease (CAD), yet the peripheral immune profile in CAD remains insufficiently characterized. This study aimed to assess circulating lymphocyte subsets in CAD patients and their potential clinical relevance. Peripheral blood from 48 patients with angiographically confirmed CAD and 14 age- and sex-matched controls was analyzed using flow cytometry. A comprehensive antibody panel was used to characterize T, B, and NK cell populations. Multiple comparisons were corrected using the Benjamini–Hochberg procedure. Q values represent false discovery rate–adjusted p values. Among subsets analyzed, only effector memory (EM) CD4⁺ and PD-1⁺ CD4⁺ T cells were significantly elevated in CAD patients. EM CD4⁺ cells showed higher counts (147 vs. 102 cells/µL) and proportions (23.9% vs. 15.2%) compared to controls, and PD-1⁺ CD4⁺ cells showed similar increases (160 vs. 95 cells/µL; 23.6% vs. 13.5%). After adjusting for high-sensitivity C-reactive protein (hsCRP), both subsets remained positively correlated with monocyte counts and inversely associated with total bilirubin levels. Furthermore, EM CD4⁺ T cells showed positive associations with circulating IL-1β (r = 0.487, p < 0.001, q = 0.035) and IL-8 (r = 0.471, p < 0.001, q = 0.04) levels, whereas PD-1⁺ CD4⁺ T cells demonstrated negative associations with IL-4 (r = − 0.537, p < 0.001, q = 0.018) and IL-10 (r = − 0.522, p < 0.001, q = 0.026). In conclusion, EM and PD-1⁺ CD4⁺ T cells are selectively enriched in CAD patients and show consistent associations with monocytes, total bilirubin, and circulating cytokines independent of hsCRP, reflecting immune alterations beyond systemic inflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.